Latest Food and Drug Administration Stories
LAGUNA HILLS, Calif., Feb.
CALGARY, Feb. 11, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
Trial in Philadelphia involves allegations that Janssen Pharmaceuticals and parent company, Johnson & Johnson, failed to warn about the risks of male breast growth, a condition known as gynecomastia,
The FDA has decided that it will not regulate a class of low-risk products it calls general wellness products.
TAMPA, Fla., Feb. 10, 2015 /PRNewswire/ -- Oxis International, Inc.
Cost-effective, high-quality production of API using microbial expression systems BOONTON, N.J., Feb.
Pennsylvania Senator Robert Casey says that the U.S.
A recent analysis of 2014 Form 483s issued to devicemakers found that purchasing control violations were up 17% over 2013. Join FDAnews on Feb.
ROCKVILLE, Md., Feb. 9, 2015 /PRNewswire/ -- CASI Pharmaceuticals, Inc.
CALGARY, Feb. 9, 2015 /PRNewswire/ - Oncolytics Biotech Inc.
Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...
The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...
- In medieval musical notation, a sign or neume denoting a shake or trill.